Breast cancer

• Cannabinoids and triple-negative breast cancer treatment (03 Sep 2024)
  
• Heterogeneity in hormone-dependent breast cancer and therapy: Steroid hormones, HER2, melanoma antigens, and cannabinoid receptors (02 Sep 2024)
  
• Cannabinoid Conference 2022 (27 Aug 2024)
  
• Modulation of breast cancer cell viability by a cannabinoid receptor 2 (18 Aug 2024)
  
• Effect of combining CBD with standard breast cancer therapeutics (31 Jul 2022)